Aayush Wellness Reports 112% Revenue Growth for FY26, Profit Up 18.26%

HEALTHCAREBIOTECH
Whalesbook Corporate News Logo
AuthorKavya Nair|Published at:
Aayush Wellness Reports 112% Revenue Growth for FY26, Profit Up 18.26%
Overview

Aayush Wellness Limited posted a strong 112% year-on-year revenue growth for FY26, reaching ₹155.48 crore. Annual net profit rose 18.26% to ₹3.98 crore. However, Q4 FY26 net profit declined compared to the previous year.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Aayush Wellness Limited FY26 Results

Revenue from operations for FY26 reached ₹155.48 crore, marking a 112% year-on-year increase.
Net profit for FY26 stood at ₹3.98 crore, an 18.26% rise from the previous year.

Reader Takeaway: Strong annual revenue growth driven by product expansion, but quarterly profit decline needs monitoring.

What just happened

Aayush Wellness Limited announced its consolidated financial results for the fiscal year ending March 31, 2026 (FY26) and the fourth quarter (Q4 FY26). The company reported a significant 112% year-on-year increase in revenue from operations, which grew from ₹73.35 crore in FY25 to ₹155.48 crore in FY26. Annual net profit also saw an increase of 18.26%, reaching ₹3.98 crore in FY26 compared to ₹3.37 crore in FY25.

However, the company's performance in the fourth quarter presented a mixed picture. While Q4 FY26 revenue grew to ₹48.41 crore from ₹22.35 crore in Q4 FY25, the net profit for Q4 FY26 declined to ₹0.56 crore from ₹1.09 crore in the same quarter last year.

Why this matters

The substantial annual revenue growth indicates Aayush Wellness is successfully expanding its market reach and product sales. The company's focus on preventive healthcare, nutraceuticals, and condition-specific products appears to be resonating with consumers. However, the decline in quarterly net profit suggests potential pressures on margins or increased operational expenses in the short term, which investors will closely watch.

The backstory

Aayush Wellness is actively growing its product portfolio in areas like immunity, brain health, sleep, and liver care. Recent additions include 'Liver Detox Tablets', reflecting the company's strategy to tap into specific health segments. This expansion aims to capture a larger share of the growing wellness market.

What changes now

Investors will be looking for continued revenue momentum in the coming quarters, supported by the expanded product range. The key focus will be on the company's ability to translate this revenue growth into improved quarterly profitability, indicating operational efficiency and margin management.

Risks to watch

The decline in Q4 FY26 net profit compared to the previous year is a key risk. Investors should monitor if this trend continues and what factors are contributing to margin pressure. Maintaining profitability while scaling operations in a competitive market is crucial.

Peer comparison

(No specific peer comparison data was provided in the filing. Aayush Wellness operates in the broadly defined healthcare and wellness sector, which includes pharmaceuticals, nutraceuticals, and health supplements.)

Context metrics (time-bound)

  • FY26 Revenue: ₹155.48 crore (up 112% YoY)
  • FY25 Revenue: ₹73.35 crore
  • FY26 Net Profit: ₹3.98 crore (up 18.26% YoY)
  • FY25 Net Profit: ₹3.37 crore
  • Q4 FY26 Revenue: ₹48.41 crore
  • Q4 FY25 Revenue: ₹22.35 crore
  • Q4 FY26 Net Profit: ₹0.56 crore
  • Q4 FY25 Net Profit: ₹1.09 crore

What to track next

Investors should monitor the company's guidance for FY27, its ability to sustain the high revenue growth rate, and crucially, its performance on profitability, especially during the quarterly results announcements.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.